Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution
- PMID: 20400241
- PMCID: PMC4086644
- DOI: 10.1016/j.ijrobp.2010.01.034
Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution
Abstract
Purpose: To provide the long-term outcomes of patients treated with fractionated conformal radiotherapy (FCRT) for presumed optic nerve sheath meningiomas (ONSMs).
Patients and methods: Between 1995 and 2002, 9 patients with a presumed ONSM were treated with FCRT at our institution. The indications for FCRT were significant visual dysfunction at presentation, progression of visual dysfunction during a period of observation, tumor growth documented by sequential imaging, or a combination of these findings. In 2 patients, FCRT was performed as adjuvant therapy, and in 7, it was the initial and primary treatment.
Results: Of the 9 patients, 6 were women and 3 were men, with a mean age of 47 years. All 9 patients had evidence of optic nerve dysfunction in the affected eye, characterized by reduced visual acuity, a visual field defect, and a relative afferent pupillary defect. In addition, 2 patients had proptosis and 1 had diplopia. The mean follow-up period was 98 ± 31.7 months (median, 90; range, 61-151). After FCRT, the visual function improved in the 7 patients who had undergone FCRT as the primary treatment. However, 2 patients who were blind in their affected eye at FCRT remained blind. In 4 of the 7 patients with improvement, the improvement was documented within 1-3 months after FCRT. The tumor control rate was 100%. Proptosis and diplopia also regressed in 100% of patients. At 2 years after FCRT, 1 patient had developed radiation retinopathy.
Conclusion: The results of our study have shown that FCRT is a safe and effective treatment of ONSMs, affording satisfactory long-term tumor control, good functional outcome, and low treatment morbidity. FCRT should be considered the treatment of choice for patients with presumed ONSMs for whom the treatment has been deemed appropriate.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest: none.
Figures
Similar articles
-
Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1166-72. doi: 10.1016/j.ijrobp.2008.12.056. Epub 2009 May 4. Int J Radiat Oncol Biol Phys. 2009. PMID: 19406585
-
Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.Br J Ophthalmol. 2019 Oct;103(10):1436-1440. doi: 10.1136/bjophthalmol-2018-313135. Epub 2018 Dec 20. Br J Ophthalmol. 2019. PMID: 30573496
-
Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma.Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):773-8. doi: 10.1016/j.ijrobp.2010.11.018. Epub 2011 Feb 6. Int J Radiat Oncol Biol Phys. 2012. PMID: 21300458
-
Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.Br J Ophthalmol. 2010 May;94(5):559-63. doi: 10.1136/bjo.2009.167346. Epub 2009 Dec 3. Br J Ophthalmol. 2010. PMID: 19965820 Review.
-
Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice.Cancer. 2007 Aug 15;110(4):714-22. doi: 10.1002/cncr.22859. Cancer. 2007. PMID: 17582618 Review.
Cited by
-
Optic Nerve Sheath Meningioma: Preliminary Analysis of the Role of Radiation Therapy.Brain Tumor Res Treat. 2018 Apr;6(1):8-12. doi: 10.14791/btrt.2018.6.e2. Epub 2018 Apr 2. Brain Tumor Res Treat. 2018. PMID: 29644809 Free PMC article.
-
Effectiveness and Safety of Robotic Radiosurgery for Optic Nerve Sheath Meningiomas: A Single Institution Series.Cancers (Basel). 2021 Apr 30;13(9):2165. doi: 10.3390/cancers13092165. Cancers (Basel). 2021. PMID: 33946405 Free PMC article.
-
Comparative analysis of somatostatin analog uptake between successfully irradiated and non-irradiated meningiomas.Einstein (Sao Paulo). 2022 Nov 25;20:eAO0104. doi: 10.31744/einstein_journal/2022AO0104. eCollection 2022. Einstein (Sao Paulo). 2022. PMID: 36449758 Free PMC article.
-
The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report.Front Oncol. 2018 Oct 16;8:454. doi: 10.3389/fonc.2018.00454. eCollection 2018. Front Oncol. 2018. PMID: 30386741 Free PMC article.
-
Prolonged vision return after radiosurgery for an optic nerve-sheath meningioma.J Radiosurg SBRT. 2012;2(1):73-77. J Radiosurg SBRT. 2012. PMID: 29296344 Free PMC article.
References
-
- Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol. 1992;37:167–183. - PubMed
-
- Kennerdell JS, Maroon JC, Malton M, et al. The management of optic nerve sheath meningiomas. Am J Ophthalmol. 1988;106:450–457. - PubMed
-
- Liu JK, Forman S, Moorthy CR, et al. Update on treatment modalities for optic nerve sheath meningiomas. Neurosurg Focus. 2003;14:e7. - PubMed
-
- Andrews DW, Faroozan R, Yang BP, et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: Preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002;51:890–903. 894. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical